Introduction: Many types of research have been performed to improve the diagnosis, therapy, and prognosis of oropharyngeal carcinomas (OP-SCCs). Since they arise in lymphoid-rich areas and intense lymphocytic infiltration has been related to a better prognosis, a TREM-1 putative function in tumour progression and survival has been hypothesized. Materials and methods: Twenty-seven human papillomavirus (HPV) 16+ OP-SCC specimens have been analyzed to relate TREM-1 expression with histiocytic and lymphocytic markers, HPV presence and patients’ outcome. Results: No differences have been shown between intratumoral and stromal CD4+ cells, while intratumoral CD8+ lymphocytes are higher with respect to the tumour stroma (p=.0005). CD68+ cells are more than CD35+ and TREM-1+; their presence is related to CD35± and TREM-1± histiocytes (p=.005 and.026, respectively). Intratumoral CD4+ lymphocytes are higher in p16+ cases (11/27) than in p16− (p=.042); moreover, p16 positivity correlates to a better survival (p=.034). CD4+, CD8+ and CD35+ cells have no impact on survival, while CD68 expression heavily influences progression and bad outcome (p=.037). TREM-1 positivity also leads to worst overall survival (p=.001): peritumoral expression and death-cause relationship are always significant, particularly when the cause is OP-SCC (p=.000). Conclusion: While p16 shows to better stratify HPV16+ patients’ outcome, TREM-1+ macrophages suggest their key importance in HPV-related OP-SCCs progression.KEY MESSAGES TREM-1 positivity correlates to the worst overall survival of HPV16-positive OPSCCs-affected patients. p16-positive HPV16 related OPSCCs patients have a better prognosis with respect to p16-negative ones.

Macrophages expressing TREM-1 are involved in the progression of HPV16-related oropharyngeal squamous cell carcinoma

Raimondo L.;Rosso T.;Aluffi Valletti P.;Pecorari G.;Giovarelli M.;
2021-01-01

Abstract

Introduction: Many types of research have been performed to improve the diagnosis, therapy, and prognosis of oropharyngeal carcinomas (OP-SCCs). Since they arise in lymphoid-rich areas and intense lymphocytic infiltration has been related to a better prognosis, a TREM-1 putative function in tumour progression and survival has been hypothesized. Materials and methods: Twenty-seven human papillomavirus (HPV) 16+ OP-SCC specimens have been analyzed to relate TREM-1 expression with histiocytic and lymphocytic markers, HPV presence and patients’ outcome. Results: No differences have been shown between intratumoral and stromal CD4+ cells, while intratumoral CD8+ lymphocytes are higher with respect to the tumour stroma (p=.0005). CD68+ cells are more than CD35+ and TREM-1+; their presence is related to CD35± and TREM-1± histiocytes (p=.005 and.026, respectively). Intratumoral CD4+ lymphocytes are higher in p16+ cases (11/27) than in p16− (p=.042); moreover, p16 positivity correlates to a better survival (p=.034). CD4+, CD8+ and CD35+ cells have no impact on survival, while CD68 expression heavily influences progression and bad outcome (p=.037). TREM-1 positivity also leads to worst overall survival (p=.001): peritumoral expression and death-cause relationship are always significant, particularly when the cause is OP-SCC (p=.000). Conclusion: While p16 shows to better stratify HPV16+ patients’ outcome, TREM-1+ macrophages suggest their key importance in HPV-related OP-SCCs progression.KEY MESSAGES TREM-1 positivity correlates to the worst overall survival of HPV16-positive OPSCCs-affected patients. p16-positive HPV16 related OPSCCs patients have a better prognosis with respect to p16-negative ones.
2021
53
1
541
550
Human papillomavirus (HPV); oropharyngeal squamous cell carcinoma (OP-SCCs); peritumoral and intratumoral infiltration; triggering receptor expressed on myeloid cells-1 (TREM-1); tumoral microenvironment (TME); Adult; Aged; Disease Progression; Female; Head and Neck Neoplasms; Humans; Macrophages; Male; Middle Aged; Papillomavirus Infections; Prognosis; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Triggering Receptor Expressed on Myeloid Cells-1; Human papillomavirus 16
Azzimonti B.; Raimondo L.; Squarzanti D.F.; Rosso T.; Zanetta P.; Aluffi Valletti P.; Chiusa L.; Masini L.; Pecorari G.; Airoldi M.; Krengli M.; Giovarelli M.; Valente G.
File in questo prodotto:
File Dimensione Formato  
07853890.2021.pdf

Accesso aperto

Tipo di file: PDF EDITORIALE
Dimensione 2.59 MB
Formato Adobe PDF
2.59 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1838583
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 3
social impact